The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Acetylcysteine Essential-Healthcare 600 mg effervescent tablets



Ascot Laboratories (Ireland) LimitedPA23163/003/001

Main Information

Trade NameAcetylcysteine Essential-Healthcare 600 mg effervescent tablets
Active SubstancesACETYLCYSTEIN
Dosage FormEffervescent tablet
Licence HolderAscot Laboratories (Ireland) Limited
Licence NumberPA23163/003/001

Group Information

ATC CodeR05CB Mucolytics
R05CB01 acetylcysteine

Status

License statusAuthorised
Licence Issued29/03/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back